ALKBH7 mediates necrosis via rewiring of glyoxal metabolism

  1. Chaitanya A Kulkarni
  2. Sergiy M Nadtochiy
  3. Leslie Kennedy
  4. Jimmy Zhang
  5. Sophea Chhim
  6. Hanan Alwaseem
  7. Elizabeth Murphy
  8. Dragony Fu
  9. Paul S Brookes  Is a corresponding author
  1. Univeristy of Rochester Medical Center, United States
  2. University of Rochester Medical Center, United States
  3. National Institutes of Health, United States
  4. University of Rochester, United States

Abstract

Alkb homolog 7 (ALKBH7) is a mitochondrial α-ketoglutarate dioxygenase required for DNA alkylation induced necrosis, but its function and substrates remain unclear. Herein we show ALKBH7 regulates dialdehyde metabolism, which impacts the cardiac response to ischemia-reperfusion (IR) injury. Using a multi-omics approach, we find no evidence ALKBH7 functions as a prolyl-hydroxylase, but we do find Alkbh7-/- mice have elevated glyoxalase I (GLO-1), a dialdehyde detoxifying enzyme. Metabolic pathways related to the glycolytic by-product methylglyoxal (MGO) are rewired in Alkbh7-/- mice, along with elevated levels of MGO protein adducts. Despite greater glycative stress, hearts from Alkbh7-/- mice are protected against IR injury, in a manner blocked by GLO-1 inhibition. Integrating these observations, we propose ALKBH7 regulates glyoxal metabolism, and that protection against necrosis and cardiac IR injury bought on by ALKBH7 deficiency originates from the signaling response to elevated MGO stress.

Data availability

The complete original data set used to generate all figures is attached as a Microsoft Excel file, with the submitted files. A DOI has been reserved at the data sharing site FigShare (DOI: 10.6084/m9.figshare.12200273) and the file has been uploaded there.

Article and author information

Author details

  1. Chaitanya A Kulkarni

    Anesthesiology, Univeristy of Rochester Medical Center, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6836-0518
  2. Sergiy M Nadtochiy

    Anesthesiology, University of Rochester Medical Center, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Leslie Kennedy

    NHLBI Intramural Research Program, National Institutes of Health, Bethesda, MD, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Jimmy Zhang

    Anesthesiology, University of Rochester Medical Center, Rochester, NY, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Sophea Chhim

    Biology, University of Rochester, Rochester, NY, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Hanan Alwaseem

    Chemistry, University of Rochester, Rochester, NY, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Elizabeth Murphy

    NHLBI Intramural Research Program, National Institutes of Health, Bethesda, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Dragony Fu

    Biology, University of Rochester, Rochester, NY, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8725-8658
  9. Paul S Brookes

    Anesthesiology, University of Rochester Medical Center, Rochester, United States
    For correspondence
    paul_brookes@urmc.rochester.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8639-8413

Funding

National Institutes of Health (R01-HL071158)

  • Paul S Brookes

American Heart Association (#19POST34380212)

  • Chaitanya A Kulkarni

NIH Office of the Director (ZO1-HL002066)

  • Leslie Kennedy
  • Elizabeth Murphy

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal work was conducted according to the "NIH Guide" (8th edition, 2011). Animals were housed in an AAALAC accredited facility with food and water available ad libitum. All procedures were performed under tribromoethanol anesthesia. All animal work was approved by the University of Rochester Committee on Animal Resources (UCAR protocol # 2007-087).

Reviewing Editor

  1. Arduino A Mangoni, Flinders Medical Centre, Australia

Publication history

  1. Received: May 5, 2020
  2. Accepted: August 13, 2020
  3. Accepted Manuscript published: August 14, 2020 (version 1)
  4. Version of Record published: August 21, 2020 (version 2)

Copyright

© 2020, Kulkarni et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,169
    Page views
  • 144
    Downloads
  • 8
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Chaitanya A Kulkarni
  2. Sergiy M Nadtochiy
  3. Leslie Kennedy
  4. Jimmy Zhang
  5. Sophea Chhim
  6. Hanan Alwaseem
  7. Elizabeth Murphy
  8. Dragony Fu
  9. Paul S Brookes
(2020)
ALKBH7 mediates necrosis via rewiring of glyoxal metabolism
eLife 9:e58573.
https://doi.org/10.7554/eLife.58573
  1. Further reading

Further reading

    1. Cell Biology
    2. Genetics and Genomics
    Nicholas P Lesner, Xun Wang ... Prashant Mishra
    Research Article

    Mitochondrial electron transport chain (ETC) dysfunction due to mutations in the nuclear or mitochondrial genome is a common cause of metabolic disease in humans and displays striking tissue specificity depending on the affected gene. The mechanisms underlying tissue specific phenotypes are not understood. Complex I (cI) is classically considered the entry point for electrons into the ETC, and in vitro experiments indicate that cI is required for basal respiration and maintenance of the NAD+/NADH ratio, an indicator of cellular redox status. This finding has largely not been tested in vivo. Here, we report that mitochondrial complex I is dispensable for homeostasis of the adult mouse liver; animals with hepatocyte-specific loss of cI function display no overt phenotypes or signs of liver damage, and maintain liver function, redox and oxygen status. Further analysis of cI-deficient livers did not reveal significant proteomic or metabolic changes, indicating little to no compensation is required in the setting of complex I loss. In contrast, complex IV (cIV) dysfunction in adult hepatocytes results in decreased liver function, impaired oxygen handling, steatosis, and liver damage, accompanied by significant metabolomic and proteomic perturbations. Our results support a model whereby complex I loss is tolerated in the mouse liver because hepatocytes use alternative electron donors to fuel the mitochondrial ETC.

    1. Cell Biology
    2. Developmental Biology
    Audrey Miller Williams, Seth Donoughe ... Sally Horne-Badovinac
    Research Article

    For a group of cells to migrate together, each cell must couple the polarity of its migratory machinery with that of the other cells in the cohort. Although collective cell migrations are common in animal development, little is known about how protrusions are coherently polarized among groups of migrating epithelial cells. We address this problem in the collective migration of the follicular epithelial cells in Drosophila melanogaster. In this epithelium, the cadherin Fat2 localizes to the trailing edge of each cell and promotes the formation of F-actin-rich protrusions at the leading edge of the cell behind. We show that Fat2 performs this function by acting in trans to concentrate the activity of the WASP family verprolin homolog regulatory complex (WAVE complex) at one long-lived region along each cell's leading edge. Without Fat2, the WAVE complex distribution expands around the cell perimeter and fluctuates over time, and protrusive activity is reduced and unpolarized. We further show that Fat2's influence is very local, with sub-micron-scale puncta of Fat2 enriching the WAVE complex in corresponding puncta just across the leading-trailing cell-cell interface. These findings demonstrate that a trans interaction between Fat2 and the WAVE complex creates stable regions of protrusive activity in each cell and aligns the cells' protrusions across the epithelium for directionally persistent collective migration.